DA32 Sponsor LLC - Aug 5, 2021 Form 4 Insider Report for DA32 Life Science Tech Acquisition Corp. (DALS)

Role
10%+ Owner
Signature
/s/ Henrikki Harsu, Attorney-in-Fact for DA32 Sponsor LLC
Stock symbol
DALS
Transactions as of
Aug 5, 2021
Transactions value $
$0
Form type
4
Date filed
8/9/2021, 07:37 PM
Previous filing
Aug 3, 2021

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction DALS Class B Common Stock, par value $0.0001 per share Other $0 -701K -13.57% $0.00 4.47M Aug 5, 2021 Class A Common Stock 701K Direct F1, F2, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 DA32 Sponsor LLC (the "Reporting Person") is the record holder of the securities reported herein. Deerfield Partners, L.P., ARCH Venture Fund XI, L.P. and Section 32 Fund 3, LP are the managing members of the Reporting Person, and share voting and investment discretion with respect to the common stock held of record by the Reporting Person. Each of the foregoing entities disclaim beneficial ownership of these shares except to the extent of any pecuniary interest therein.
F2 The shares of Class B Common Stock are convertible into shares of the Issuer's Class A Common Stock as described under the heading "Description of Shares" in the Issuer's Registration Statement on Form S-1 (File No. 333-257679) (the "Registration Statement") and have no expiration date.
F3 On August 5, 2021, the Reporting Person forfeited 701,250 shares of Class B common stock to the Issuer for no consideration, in connection with the underwriters' election to forfeit their overallotment option on August 4, 2021. The forfeiture was not within the Reporting Person's control as it occurred exclusively due to the underwriters' decision not to exercise the overallotment option and occurred shortly after the Issuer filed the final statutory prospectus for the initial public offering (the "IPO") disclosing all material information about the Issuer and the IPO.